Serotonin receptors in depression: from A to B
- PMID: 28232871
- PMCID: PMC5302148
- DOI: 10.12688/f1000research.9736.1
Serotonin receptors in depression: from A to B
Abstract
The role of serotonin in major depressive disorder (MDD) is the focus of accumulating clinical and preclinical research. The results of these studies reflect the complexity of serotonin signaling through many receptors, in a large number of brain regions, and throughout the lifespan. The role of the serotonin transporter in MDD has been highlighted in gene by environment association studies as well as its role as a critical player in the mechanism of the most effective antidepressant treatments - selective serotonin reuptake inhibitors. While the majority of the 15 known receptors for serotonin have been implicated in depression or depressive-like behavior, the serotonin 1A (5-HT 1A) and 1B (5-HT 1B) receptors are among the most studied. Human brain imaging and genetic studies point to the involvement of 5-HT 1A and 5-HT 1B receptors in MDD and the response to antidepressant treatment. In rodents, the availability of tissue-specific and inducible knockout mouse lines has made possible the identification of the involvement of 5-HT 1A and 5-HT 1B receptors throughout development and in a cell-type specific manner. This, and other preclinical pharmacology work, shows that autoreceptor and heteroreceptor populations of these receptors have divergent roles in modulating depression-related behavior as well as responses to antidepressants and also have different functions during early postnatal development compared to during adulthood.
Keywords: 5-HT1A; 5-HT1B; 5-HTT; MDD; antidepressant; major depressive disorder; selective serotonin reuptake inhibitors; serotonin; serotonin receptor.
Conflict of interest statement
Competing interests: The authors declare that they have no competing interests.No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Figures
Similar articles
-
The 5-HT1B receptor: a novel target for the pathophysiology of depression.Curr Drug Targets. 2009 Nov;10(11):1118-38. doi: 10.2174/138945009789735192. Curr Drug Targets. 2009. PMID: 19702551 Review.
-
Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.Mol Neurobiol. 2016 Jul;53(5):2778-2786. doi: 10.1007/s12035-015-9152-z. Epub 2015 Apr 1. Mol Neurobiol. 2016. PMID: 25823514 Review.
-
5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.Eur J Pharmacol. 2005 Dec 5;526(1-3):125-39. doi: 10.1016/j.ejphar.2005.09.065. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16310183 Review.
-
Overcoming Resistance to Selective Serotonin Reuptake Inhibitors: Targeting Serotonin, Serotonin-1A Receptors and Adult Neuroplasticity.Front Neurosci. 2019 Apr 30;13:404. doi: 10.3389/fnins.2019.00404. eCollection 2019. Front Neurosci. 2019. PMID: 31114473 Free PMC article. Review.
-
Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study.Biol Psychiatry. 2006 Jan 15;59(2):106-13. doi: 10.1016/j.biopsych.2005.06.016. Epub 2005 Sep 9. Biol Psychiatry. 2006. PMID: 16154547 Clinical Trial.
Cited by
-
Psychopharmacological Approaches for Neural Plasticity and Neurogenesis in Major Depressive Disorders.Adv Exp Med Biol. 2024;1456:27-48. doi: 10.1007/978-981-97-4402-2_2. Adv Exp Med Biol. 2024. PMID: 39261422 Review.
-
Striatal Serotonin Release Signals Reward Value.J Neurosci. 2024 Oct 9;44(41):e0602242024. doi: 10.1523/JNEUROSCI.0602-24.2024. J Neurosci. 2024. PMID: 39117457 Free PMC article.
-
Does vitamin D supplementation impact serotonin levels? A systematic review and meta-analysis.Health Sci Rep. 2024 Jul 30;7(8):e2276. doi: 10.1002/hsr2.2276. eCollection 2024 Aug. Health Sci Rep. 2024. PMID: 39086509 Free PMC article.
-
Citalopram exposure of hESCs during neuronal differentiation identifies dysregulated genes involved in neurodevelopment and depression.Front Cell Dev Biol. 2024 Jul 11;12:1428538. doi: 10.3389/fcell.2024.1428538. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39055655 Free PMC article.
-
Evaluation of serum MIP-1β and MCP-2 levels in major depressive disorder: A case-control study.PLoS One. 2024 Jun 18;19(6):e0305734. doi: 10.1371/journal.pone.0305734. eCollection 2024. PLoS One. 2024. PMID: 38889138 Free PMC article.
References
-
- De Montigny C: Enhancement of the 5-HT neurotransmission by antidepressant treatments. J Physiol (Paris). 1981;77(2–3):455–61. - PubMed
-
- Messing RB, Phebus L, Fisher LA, et al. : Analgesic effect of fluoxetine hydrochloride (Lilly 110140), a specific inhibitor of serotonin uptake. Psychopharmacol Commun. 1975;1(5):511–21. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
